289 related articles for article (PubMed ID: 27503193)
1. Prognostic impact of tumour burden assessed by metabolic tumour volume on FDG PET/CT in anal canal cancer.
Gauthé M; Richard-Molard M; Fayard J; Alberini JL; Cacheux W; Lièvre A
Eur J Nucl Med Mol Imaging; 2017 Jan; 44(1):63-70. PubMed ID: 27503193
[TBL] [Abstract][Full Text] [Related]
2. Prognostic utility of pre- and post-treatment FDG-PET parameters in anal squamous cell carcinoma.
Duimering A; Riauka T; Nijjar Y; Ghosh S; MacEwan R; Warkentin H; Schiller D; Tankel K; Usmani N; Severin D; Nijjar T; Fairchild A; Mulder K; Doll C; Wong C; Joseph K
Radiother Oncol; 2019 Jul; 136():21-28. PubMed ID: 31015125
[TBL] [Abstract][Full Text] [Related]
3. Anal cancer chemoradiotherapy outcome prediction using
Rusten E; Rekstad BL; Undseth C; Klotz D; Hernes E; Guren MG; Malinen E
Br J Radiol; 2019 May; 92(1097):20181006. PubMed ID: 30810343
[TBL] [Abstract][Full Text] [Related]
4. The prognostic role of FDG PET/CT before combined radio-chemotherapy in anal cancer patients.
Leccisotti L; Manfrida S; Barone R; Ripani D; Tagliaferri L; Masiello V; Privitera V; Gambacorta MA; Rufini V; Valentini V; Giordano A
Ann Nucl Med; 2020 Jan; 34(1):65-73. PubMed ID: 31728763
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of volume-based 18F-FDG PET/CT parameter in patients with surgically resected non-small cell lung cancer. Comparison with immunohistochemical biomarkers.
Lee JY; Choi JY; Heo JH; Han J; Jang SJ; Kim K; Kim J; Shim YM; Kim BT
Nuklearmedizin; 2016; 55(1):7-14. PubMed ID: 26875430
[TBL] [Abstract][Full Text] [Related]
7. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA
Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677
[TBL] [Abstract][Full Text] [Related]
8. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
9. Texture analysis of
Nakajo M; Jinguji M; Nakabeppu Y; Nakajo M; Higashi R; Fukukura Y; Sasaki K; Uchikado Y; Natsugoe S; Yoshiura T
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):206-214. PubMed ID: 27613542
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
12. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma.
Sun Y; Lu P; Yu L
Acad Radiol; 2016 May; 23(5):605-10. PubMed ID: 26853968
[TBL] [Abstract][Full Text] [Related]
13. Role of 18F-FDG PET-derived parameters for predicting complete response to chemoradiotherapy in squamous cell anal carcinoma.
Filippi L; Fontana A; Spinelli GP; Rossi L; Bagni O
Nucl Med Commun; 2020 Oct; 41(10):1089-1094. PubMed ID: 32732599
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
15. Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canal.
Bazan JG; Koong AC; Kapp DS; Quon A; Graves EE; Loo BW; Chang DT
J Nucl Med; 2013 Jan; 54(1):27-32. PubMed ID: 23236018
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of volumetric FDG PET/CT parameters in patients with oral tongue squamous cell carcinoma who were treated by superselective intra-arterial chemoradiotherapy.
Suzuki-Shibata S; Yamamoto Y; Yoshida T; Mizoguchi N; Nonaka T; Kubota A; Narimatsu H; Miyagi Y; Kobayashi T; Kaneta T; Inoue T
Jpn J Radiol; 2017 Dec; 35(12):740-747. PubMed ID: 29039110
[TBL] [Abstract][Full Text] [Related]
18. Nodal parameters of FDG PET/CT performed during radiotherapy for locally advanced mucosal primary head and neck squamous cell carcinoma can predict treatment outcomes: SUVmean and response rate are useful imaging biomarkers.
Lin P; Min M; Lee M; Holloway L; Forstner D; Bray V; Fowler A
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):801-811. PubMed ID: 28004135
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.
Hyun SH; Choi JY; Shim YM; Kim K; Lee SJ; Cho YS; Lee JY; Lee KH; Kim BT
Ann Surg Oncol; 2010 Jan; 17(1):115-22. PubMed ID: 19826877
[TBL] [Abstract][Full Text] [Related]
20. Anal cancer FDG-PET standard uptake value: correlation with tumor characteristics, treatment response and survival.
Deantonio L; Milia ME; Cena T; Sacchetti G; Perotti C; Brambilla M; Turri L; Krengli M
Radiol Med; 2016 Jan; 121(1):54-9. PubMed ID: 26126968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
